Maxime Meylan
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 18
-
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Catherine Sautès‐Fridman (14 shared papers)Wolf H. Fridman (11 shared papers)Florent Petitprez (6 shared papers)Cheng‐Ming Sun (4 shared papers)Aurélien de Reyniès (2 shared papers)Antoîne Italiano (1 shared paper)Anne Calvez (1 shared paper)Guilhem Pupier (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Clinical Cancer Research (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Frontiers in Immunology (3 papers)Cancer Immunology Research (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Maxime Meylan
30 papers receiving 2.7k citations
Maxime Meylan's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 1.5k
- Immunology 573
- Genetics 120
- Pulmonary and Respiratory Medicine 410
- Cancer Research 159
Countries citing papers authored by Maxime Meylan
This map shows the geographic impact of Maxime Meylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Meylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Meylan more than expected).
Fields of papers citing papers by Maxime Meylan
This network shows the impact of papers produced by Maxime Meylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Meylan. The network helps show where Maxime Meylan may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Meylan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer Hit paper breakdown → | 2022 | 568 |
| 2 | B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome Hit paper breakdown → | 2022 | 502 |
| 3 | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies Hit paper breakdown → | 2020 | 441 |
| 4 | Tertiary lymphoid structures and B cells: An intratumoral immunity cycle Hit paper breakdown → | 2023 | 215 |
| 5 | 2020 | 163 | |
| 6 | 2020 | 112 | |
| 7 | 2022 | 103 | |
| 8 | 2020 | 94 | |
| 9 | 2020 | 90 | |
| 10 | 2022 | 88 | |
| 11 | 2020 | 70 | |
| 12 | 2021 | 69 | |
| 13 | 2021 | 65 | |
| 14 | 2022 | 41 | |
| 15 | 2021 | 36 | |
| 16 | 2021 | 12 | |
| 17 | 2023 | 10 | |
| 18 | 2026 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2023 | 7 |
About Maxime Meylan
Maxime Meylan is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Genetics and Infectious Diseases, having authored 31 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Renal cell carcinoma treatment (10 papers), Glioma Diagnosis and Treatment (3 papers), T-cell and B-cell Immunology (3 papers), COVID-19 Clinical Research Studies (2 papers), Immune Cell Function and Interaction (2 papers), Immunotherapy and Immune Responses (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (573 citations), Genetics (120 citations), Pulmonary and Respiratory Medicine (410 citations) and Cancer Research (159 citations). Maxime Meylan has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Catherine Sautès‐Fridman, Wolf H. Fridman, Florent Petitprez, Cheng‐Ming Sun, Aurélien de Reyniès, Antoîne Italiano, Anne Calvez, Guilhem Pupier, Isaias Hernández-Verdín and Tom Wei‐Wu Chen. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.